161 related articles for article (PubMed ID: 33963606)
1. Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach.
Talia KL; Parra-Herran C; McCluggage WG
Histopathology; 2022 Jan; 80(2):255-278. PubMed ID: 33963606
[TBL] [Abstract][Full Text] [Related]
2. Fascin and EMMPRIN expression in primary mucinous tumors of ovary: a tissue microarray study.
Alici O; Kefeli M; Yildiz L; Baris S; Karagoz F; Kandemir B
Pathol Res Pract; 2014 Dec; 210(12):934-8. PubMed ID: 25155376
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M
J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911
[TBL] [Abstract][Full Text] [Related]
4. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature.
Ates Ozdemir D; Usubutun A
Pathol Oncol Res; 2016 Jul; 22(3):593-9. PubMed ID: 26797858
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms.
McCluggage WG
J Clin Pathol; 2012 Jul; 65(7):596-600. PubMed ID: 21768188
[TBL] [Abstract][Full Text] [Related]
6. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
7. Mucinous Ovarian Tumors.
Mills AM; Shanes ED
Surg Pathol Clin; 2019 Jun; 12(2):565-585. PubMed ID: 31097115
[TBL] [Abstract][Full Text] [Related]
8. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive.
Vang R; Gown AM; Barry TS; Wheeler DT; Ronnett BM
Int J Gynecol Pathol; 2006 Jan; 25(1):83-9. PubMed ID: 16306790
[TBL] [Abstract][Full Text] [Related]
9. Pathology of primary and metastatic mucinous ovarian neoplasms.
Leen SL; Singh N
J Clin Pathol; 2012 Jul; 65(7):591-5. PubMed ID: 22075188
[TBL] [Abstract][Full Text] [Related]
10. SWI/SNF protein and claudin-4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum.
Chaudet K; Kem M; Lerwill M; Young RH; Mino-Kenudson M; Agaimy A; McCluggage WG; Oliva E
Histopathology; 2020 Aug; 77(2):231-239. PubMed ID: 32268438
[TBL] [Abstract][Full Text] [Related]
11. Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature.
Idrees R; Din NU; Siddique S; Fatima S; Abdul-Ghafar J; Ahmad Z
J Ovarian Res; 2021 Mar; 14(1):47. PubMed ID: 33736662
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
Strickland S; Parra-Herran C
Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
[TBL] [Abstract][Full Text] [Related]
13. Diffusely Metastasized Adenocarcinoma Arising in a Mucinous Carcinoid of the Ovary: A Case Report.
Van Rompuy AS; Vanderstichele A; Vergote I; Moerman P
Int J Gynecol Pathol; 2018 May; 37(3):290-295. PubMed ID: 28463910
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases.
Vang R; Gown AM; Barry TS; Wheeler DT; Ronnett BM
Mod Pathol; 2006 Jan; 19(1):97-105. PubMed ID: 16294196
[TBL] [Abstract][Full Text] [Related]
16. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors.
Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M
Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358
[TBL] [Abstract][Full Text] [Related]
17. Mucinous tumours of the ovary--primary and metastatic.
Heatley MK
J Clin Pathol; 2012 Jul; 65(7):577-9. PubMed ID: 22081785
[No Abstract] [Full Text] [Related]
18. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
Saied EM; El-Etreby NM
Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
[TBL] [Abstract][Full Text] [Related]
19. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
Taylor J; McCluggage WG
Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
[TBL] [Abstract][Full Text] [Related]
20. FOXA1 is expressed in ovarian mucinous neoplasms.
Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M
Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]